A subsequent study demonstrated that NDKA and PARK7 were significantly increased in stroke patients compared to controls (p < 0.0001), for NDKA the sensitivity and specificity were 90% [3, 4, 8]. This evidence concerns the gene NME1 and stroke disorder.